# Akili Interactive Labs, Inc.

- Location (FDA's records): Boston,, MA
- FDA decisions: 3 (2020–2024): 2 510(k) clearances and 1 De Novo grant
- Product codes: QFT (3)
- Predicates its devices cite: 2 (2 its own); citations of its devices by later devices: 3 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Lumos Labs, Inc.: 1 (https://510kreport.com/company/lumos-labs)

## Its most-cited devices
- DEN200026: EndeavorRx (2020), cited by 3

## Recent decisions
- K233496: EndeavorOTC (Jun 14, 2024)
- K231337: EndeavorRx (Dec 13, 2023)
- DEN200026: EndeavorRx (Jun 15, 2020)

Source page: https://510kreport.com/company/akili-interactive-labs